Predictors of Pathologic Complete Response and Its Prognostic Value in Early Breast Cancer: A Real-World Cohort Study

Background: Pathologic complete response (pCR) after neoadjuvant systemic therapy (NAST) is a key prognostic marker in early breast cancer (EBC), particularly in triple-negative (TNBC) and HER2-positive subtypes. However, real-world data on predictors of pCR and their impact on survival remain limit...

Descripción completa

Detalles Bibliográficos

Autores principales:	Selami Bayram, Ali Murat Tatli, Muharrem Okan Cakir, Mustafa Ozdogan
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2025-10-01
Colección:	Current Oncology
Materias:	breast neoplasms early breast cancer neoadjuvant therapy pathologic complete response prognosis predictive biomarkers
Acceso en línea:	https://www.mdpi.com/1718-7729/32/11/603
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!